In an August 27th release, BioChek of Reeuwijk.Holland and Bio-X of Namur, Belgium announced a strategic partnership relating to their respective concentrations on poultry and ruminant diagnostic kits. BioChek will also acquire a minority share in Bio-X.
Barend van Dam, CEO of BioChek, commented, “The business philosophy of our two companies is very similar. State-of-the-art diagnostics and superior support for our customers is what we achieve.”
Philippe Hivorel, CEO of Bio-X, commented, “This partnership will enable Bio-X to offer our products worldwide. Prior to the agreement, we cooperated with BioChek on several products and learned to appreciate their collegial way of working.”
BioChek has an extensive portfolio of veterinary diagnostic kits for poultry and swine diseases. Bio-X diagnostics specializes in rapid-detection point-of-care products including CellSense® diagnosis of subclinical mastitis, a newly 
introduced PCR assay for bluetongue virus type 3, Clostridium perfringens in cattle and PRRS in swine.
BioChek operates an administrative facility in the Netherlands, R&D in the U.K. and a unit recognized by the USDA in the U.S. The strategic alliance will expedite R&D to promote animal health and will be invaluable in extending the market reach of both companies.